Butterfield Introduces Legislation to Boost American Biopharmaceutical Manufacturing Workforce
WASHINGTON, D.C. – This week, Congressman G. K. Butterfield (NC-01) introduced The Making Essential Drugs in America Act (MEDS Act). This legislation allows the Department of Health and Human Services (HHS) to award grants to institutions of higher education and certified apprenticeship programs to establish American Biopharmaceutical Manufacturing Worker Training Centers of Excellence.
“North Carolina is home to many biopharmaceutical manufacturers, and I have seen first-hand how this cutting-edge industry can strengthen our domestic supply chains, increase quantities of American-made pharmaceutical ingredients, and build a highly skilled workforce to keep our country competitive in a 21st century economy,” said Congressman Butterfield. “The MEDS Act will help us defeat the current COVID-19 crisis and better equip the United States against future pandemics. Serious investments in our country’s biopharmaceutical manufacturing workforce will not only prepare our country for the future but it will also create skilled, high-wage jobs around the county.”
The MEDS Act will create a five-year, competitive grant program at HHS for entities to develop Centers of Excellence to recruit and train biopharmaceutical manufacturing workers. Eligible entities include institutions of higher education and certified apprenticeship programs with twenty percent of awards reserved for Historically Black Colleges and Universities.